Terns Pharmaceuticals, Inc. (DELISTED) (TERN:DL)
52.95
0.00 (0.00%)
USD |
NASDAQ |
May 14, 16:00
Terns Pharmaceuticals Total Liabilities (Quarterly) : 18.73M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Merck & Co., Inc. | 82.75B |
| Corcept Therapeutics, Inc. | 176.89M |
| Eli Lilly & Co. | 85.38B |
| Bristol Myers Squibb Co. | 66.37B |
| Nektar Therapeutics | 187.06M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.025B |
| Shareholders Equity (Quarterly) | 1.007B |
| Debt to Equity Ratio | 0.0009 |
| Current Ratio | 62.41 |
| Net Debt Paydown Yield | 0.00% |